These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 19130409)

  • 21. Brain natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure.
    Wiwanitkit V
    Am Heart J; 2010 Mar; 159(3):e15; author reply e17. PubMed ID: 20211288
    [No Abstract]   [Full Text] [Related]  

  • 22. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure.
    Stoupakis G; Klapholz M
    Heart Dis; 2003; 5(3):215-23. PubMed ID: 12783635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NT-proBNP correlates not only with ejection fraction, but also with inferior vena cava diameter in patients with acute heart failure.
    Pudil R; Tichy M; Blaha V; Praus R; Vojacek J
    Clin Chim Acta; 2007 Mar; 378(1-2):230. PubMed ID: 17182022
    [No Abstract]   [Full Text] [Related]  

  • 24. Natriuretic peptide testing in heart failure.
    Kim HN; Januzzi JL
    Circulation; 2011 May; 123(18):2015-9. PubMed ID: 21555724
    [No Abstract]   [Full Text] [Related]  

  • 25. [Safe diagnosis in acute phase with T-proBNP. Heart failure and acute coronary syndrome can be identified very early].
    Javadzadeh J; Collén AC; Manhem K; Swedberg K
    Lakartidningen; 2008 Feb 27-Mar 4; 105(9):616-9. PubMed ID: 18376704
    [No Abstract]   [Full Text] [Related]  

  • 26. Natriuretic peptides: putting the evidence into practice.
    Andrade A; Sharar H
    Can J Cardiovasc Nurs; 2008; 18(4):34-9. PubMed ID: 19093420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
    Coppola G; Corrado E; Mulè MC; Augugliaro S; Cucchiara A; Novo G; Amoroso G; Assennato P; Hoffmann E; Vitale F; Novo S
    Coron Artery Dis; 2009 May; 20(3):225-9. PubMed ID: 19387249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement but no cure of left ventricular systolic dysfunction in treated heart failure patients.
    Murphy NF; O'Loughlin C; Ledwidge M; McCaffrey D; McDonald K
    Eur J Heart Fail; 2007 Dec; 9(12):1196-204. PubMed ID: 18039520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-operative cardiac risk assessment in noncardiac surgery: are natriuretic peptides the magic bullet?
    Bolliger D; Seeberger MD; Filipovic M
    J Am Coll Cardiol; 2009 Oct; 54(17):1607-8. PubMed ID: 19833259
    [No Abstract]   [Full Text] [Related]  

  • 30. Natriuretic peptides in the diagnosis and management of heart failure.
    Felker GM; Petersen JW; Mark DB
    CMAJ; 2006 Sep; 175(6):611-7. PubMed ID: 16966666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An equation to explain variations in blood NT-proBNP in ambulatory cardiac subjects.
    Suwanugsorn S; Yipintsoi T; Geater AF; Jintapakorn W; Phromminthikul A
    J Med Assoc Thai; 2009 Jan; 92(1):1-7. PubMed ID: 19260235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alveolar membrane conductance decreases as BNP increases during exercise in heart failure. Rationale for BNP in the evaluation of dyspnea.
    Cattadori G; Wasserman K; Meloni C; Mustaq S; Contini M; Apostolo A; Andreini D; Magrì D; Sciomer S; Veglia F; Berna G; Introcaso G; Palermo P; Fiorentini C; Agostoni P
    J Card Fail; 2009 Mar; 15(2):136-44. PubMed ID: 19254673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-type natriuretic peptide - a biomarker for all seasons?
    Mark DB; Felker GM
    N Engl J Med; 2004 Feb; 350(7):718-20. PubMed ID: 14960748
    [No Abstract]   [Full Text] [Related]  

  • 34. Understanding "diastolic heart failure": the tip of the iceberg.
    Nishimura RA; Jaber W
    J Am Coll Cardiol; 2007 Feb; 49(6):695-7. PubMed ID: 17291935
    [No Abstract]   [Full Text] [Related]  

  • 35. Renal and cardiac function for long-term (10 year) risk stratification after myocardial infarction.
    Palmer SC; Yandle TG; Frampton CM; Troughton RW; Nicholls MG; Richards AM
    Eur Heart J; 2009 Jun; 30(12):1486-94. PubMed ID: 19389787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The coming of age of natriuretic peptides: the emperor does have clothes!
    Maisel A
    J Am Coll Cardiol; 2006 Jan; 47(1):61-4. PubMed ID: 16386665
    [No Abstract]   [Full Text] [Related]  

  • 37. [Contra: Natriuretic peptides as diagnostic tool. Still obstacles for routine use in heart failure].
    Lindstedt G
    Lakartidningen; 2006 Mar 22-28; 103(12):930-2, 934-7. PubMed ID: 16618037
    [No Abstract]   [Full Text] [Related]  

  • 38. Measuring risk in end-stage renal disease: is N-terminal pro brain natriuretic peptide a useful marker?
    Rosner MH
    Kidney Int; 2007 Mar; 71(6):481-3. PubMed ID: 17344896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of BNP in heart failure diagnosis].
    Logeart D
    Rev Prat; 2010 Sep; 60(7):923. PubMed ID: 21033485
    [No Abstract]   [Full Text] [Related]  

  • 40. B-type natriuretic peptides and echocardiographic measures of cardiac structure and function.
    Troughton RW; Richards AM
    JACC Cardiovasc Imaging; 2009 Feb; 2(2):216-25. PubMed ID: 19356559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.